Info
Significant Ownership

Significant Ownership of Endeavour Medtech Growth II LP

Signature - Title: /s/ Nick Barton - Nick Barton / Director of Endeavour Medtech II GP Limited, its General Partner
Location: St Peter Port
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Endeavour Medtech Growth II LP.

Notify me when Endeavour Medtech Growth II LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Endeavour Medtech Growth II LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
RPID	Rapid Micro Biosystems, Inc.	Common Stock, par value $0.01	5.7%	$6,545,587		2,257,099		Endeavour Medtech Growth II LP	31 Dec 2025
KMTS	Kestra Medical Technologies, Ltd.	Common Shares, par value $1.00 per share	4.2%	$53,974,682	-$4,362,972	2,448,942	-7.5%	Endeavour Medtech Growth II LP	31 Dec 2025

Schedules 13D/G Reported by Endeavour Medtech Growth II LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.